Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaleon Regulatory News (HLN)

Share Price Information for Haleon (HLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 332.00
Bid: 332.80
Ask: 332.90
Change: 3.00 (0.91%)
Spread: 0.10 (0.03%)
Open: 330.70
High: 336.30
Low: 330.10
Prev. Close: 329.00
HLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Nov 2023 13:00

RNS Number : 1248T
Haleon PLC
10 November 2023

?HALEON PLC

?("Haleon" or "the Company")?

?

?Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

?

?10 November 2023: Notification and Public Disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Persons Closely Associated with them.

?

?On 10 November 2023, the Company received notification of the following transactions as detailed below.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bart Derde

2

Reason for the notification

a)

Position/status

Chief Supply Chain Officer - PDMR

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Haleon plc

b)

LEI

549300PSB3WWEODCUP19

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

GB00BMX86B70

b)

Nature of the transaction

Acquisition of Partnership Shares and award of Matching Shares under the Company's Share Reward Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£3.288685

38

£Nil

38 (matching shares)

d)

Aggregated information

- Aggregated volume

76

- Price

e)

Date of the transaction

9 November 2023

f)

Place of the transaction

London Stock Exchange (XLON)?

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jooyong Lee

2

Reason for the notification

a)

Position/status

Head of Strategy and Office of CEO - PDMR

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Haleon plc

b)

LEI

549300PSB3WWEODCUP19

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

GB00BMX86B70

b)

Nature of the transaction

Acquisition of Partnership Shares and award of Matching Shares under the Company's Share Reward Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£ 3.288685

38

£Nil

38 (matching shares)

d)

Aggregated information

- Aggregated volume

76

- Price

e)

Date of the transaction

9 November 2023

f)

Place of the transaction

London Stock Exchange (XLON)?

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bjarne Tellmann

2

Reason for the notification

a)

Position/status

General Counsel - PDMR

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Haleon plc

b)

LEI

549300PSB3WWEODCUP19

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.01 each

Identification code

GB00BMX86B70

b)

Nature of the transaction

Acquisition of Partnership Shares and award of Matching Shares under the Company's Share Reward Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£3.288685

38

£Nil

38 (matching shares)

d)

Aggregated information

- Aggregated volume

76

- Price

e)

Date of the transaction

9 November 2023

f)

Place of the transaction

London Stock Exchange (XLON)?

Amanda Mellor, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBDBDBIDBDGXG
Date   Source Headline
20th May 20242:45 pmRNSHolding(s) in Company
20th May 20242:15 pmRNSDirector/PDMR Shareholding
17th May 20245:30 pmRNSHaleon
8th May 20245:15 pmRNSResults of Haleon 2024 Annual General Meeting
7th May 20249:30 amRNSEMTN programme: publication of base prospectus
1st May 202411:10 amRNSDirectorate Change
1st May 20247:00 amRNSHaleon 2024 Q1 Trading Statement
24th Apr 20247:00 amRNSAppointment of Dawn Allen as CFO
12th Apr 202412:00 pmRNSNotice of Annual General Meeting (AGM)
3rd Apr 202411:30 amRNSDirector/PDMR Shareholding
2nd Apr 20249:15 amRNSTotal Voting Rights and Capital
22nd Mar 202411:30 amRNSHolding(s) in Company
21st Mar 20246:00 pmRNSHaleon
21st Mar 20244:38 pmRNSTotal Voting Rights and Capital
21st Mar 20244:05 pmRNSClosing of Secondary Global Offering by Pfizer
20th Mar 20248:39 amRNSFinal prospectus supplement filed with the SEC
19th Mar 20247:00 amRNSPricing and upsize of Secondary Global Offering
18th Mar 202411:00 amRNSPreliminary prospectus supplement filed with SEC
18th Mar 20247:00 amRNSProposed Secondary Global Offering by Pfizer Inc.
15th Mar 20243:00 pmRNSPublication of Annual Report and Form 20-F 2023
14th Mar 20244:20 pmRNSDirector/PDMR Shareholding
12th Mar 20243:30 pmRNSDirector/PDMR Shareholding
5th Mar 20242:30 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSHaleon Preliminary 2023 Full Year Results
2nd Feb 20242:15 pmRNSDirector Declaration
25th Jan 20247:00 amRNSHaleon to sell ChapStick
18th Jan 20245:00 pmRNSHolding(s) in Company
17th Jan 20246:00 pmRNSHaleon
11th Jan 20241:00 pmRNSDirector/PDMR Shareholding
19th Dec 20231:00 pmRNSDirector/PDMR Shareholding
13th Dec 202310:30 amRNSDirector/PDMR Shareholding
10th Nov 20231:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20237:00 amRNSHaleon 2023 Q3 Trading Statement
13th Oct 20233:30 pmRNSDirector/PDMR Shareholding
11th Oct 20233:00 pmRNSDirector/PDMR Shareholding
10th Oct 202311:00 amRNSHolding(s) in Company
6th Oct 20236:00 pmRNSHaleon
6th Oct 20232:30 pmRNSDirector/PDMR Shareholding
28th Sep 202311:00 amRNSDirector Declaration
13th Sep 20239:30 amRNSDirector/PDMR Shareholding
10th Aug 20231:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:00 amRNSHaleon Half Year Results 2023
13th Jul 202311:00 amRNSDirector/PDMR Shareholding
12th Jun 20231:00 pmRNSDirector/PDMR Shareholding
16th May 20232:00 pmRNSHolding(s) in Company
16th May 20232:00 pmRNSHolding(s) in Company
12th May 20235:30 pmRNSHaleon
12th May 20234:30 pmRNSDirector/PDMR Shareholding
12th May 20239:30 amRNSEMTN programme publication of base prospectus
9th May 20235:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.